Neutral tumor evolution?
Nat Genet
.
2018 Dec;50(12):1630-1633.
doi: 10.1038/s41588-018-0258-x.
Authors
Maxime Tarabichi
1
2
,
Iñigo Martincorena
2
,
Moritz Gerstung
3
,
Armand M Leroi
4
,
Florian Markowetz
5
;
PCAWG Evolution and Heterogeneity Working Group
;
Paul T Spellman
6
,
Quaid D Morris
7
,
Ole Christian Lingjærde
8
,
David C Wedge
9
10
,
Peter Van Loo
11
12
Collaborators
PCAWG Evolution and Heterogeneity Working Group
:
Stefan C Dentro
,
Ignaty Leshchiner
,
Moritz Gerstung
,
Clemency Jolly
,
Kerstin Haase
,
Maxime Tarabichi
,
Jeff Wintersinger
,
Amit G Deshwar
,
Kaixian Yu
,
Santiago Gonzalez
,
Yulia Rubanova
,
Geoff Macintyre
,
David J Adams
,
Pavana Anur
,
Rameen Beroukhim
,
Paul C Boutros
,
David D Bowtell
,
Peter J Campbell
,
Shaolong Cao
,
Elizabeth L Christie
,
Marek Cmero
,
Yupeng Cun
,
Kevin J Dawson
,
Jonas Demeulemeester
,
Nilgun Donmez
,
Ruben M Drews
,
Roland Eils
,
Yu Fan
,
Matthew Fittall
,
Dale W Garsed
,
Gad Getz
,
Gavin Ha
,
Marcin Imielinski
,
Lara Jerman
,
Yuan Ji
,
Kortine Kleinheinz
,
Juhee Lee
,
Henry Lee-Six
,
Dimitri G Livitz
,
Salem Malikic
,
Florian Markowetz
,
Iñigo Martincorena
,
Thomas J Mitchell
,
Ville Mustonen
,
Layla Oesper
,
Martin Peifer
,
Myron Peto
,
Benjamin J Raphael
,
Daniel Rosebrock
,
S Cenk Sahinalp
,
Adriana Salcedo
,
Matthias Schlesner
,
Steven Schumacher
,
Subhajit Sengupta
,
Ruian Shi
,
Seung Jun Shin
,
Lincoln D Stein
,
Ignacio Vázquez-García
,
Shankar Vembu
,
David A Wheeler
,
Tsun-Po Yang
,
Xiaotong Yao
,
Ke Yuan
,
Hongtu Zhu
,
Wenyi Wang
,
Quaid D Morris
,
Paul T Spellman
,
David C Wedge
,
Peter Van Loo
Affiliations
1
The Francis Crick Institute, London, UK.
2
Wellcome Trust Sanger Institute, Cambridge, UK.
3
European Molecular Biology Laboratory, European Bioinformatics Institute, Cambridge, UK.
4
Department of Life Sciences, Imperial College London, London, UK.
5
Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
6
Molecular and Medical Genetics, Oregon Health & Science University, Portland, OR, USA.
7
Donnelly Centre, University of Toronto and Vector Institute, Toronto, Ontario, Canada.
8
Department of Informatics and Centre for Cancer Biomedicine, University of Oslo, Oslo, Norway.
9
Big Data Institute, University of Oxford, Oxford, UK.
10
Oxford NIHR Biomedical Research Centre, Oxford, UK.
11
The Francis Crick Institute, London, UK. peter.vanloo@crick.ac.uk.
12
Department of Human Genetics, University of Leuven, Leuven, Belgium. peter.vanloo@crick.ac.uk.
PMID:
30374075
PMCID:
PMC6548558
DOI:
10.1038/s41588-018-0258-x
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Genetic Drift*
Humans
Neoplasms*
Selection, Genetic
Grants and funding
FC001202/WT_/Wellcome Trust/United Kingdom
U24 CA211000/CA/NCI NIH HHS/United States
21777/CRUK_/Cancer Research UK/United Kingdom
19274/CRUK_/Cancer Research UK/United Kingdom
WT_/Wellcome Trust/United Kingdom
202778/Z/16/Z/WT_/Wellcome Trust/United Kingdom
MR/L016311/1/MRC_/Medical Research Council/United Kingdom
FC001202/ARC_/Arthritis Research UK/United Kingdom
FC001202/MRC_/Medical Research Council/United Kingdom
R01 CA183793/CA/NCI NIH HHS/United States
R01 CA174206/CA/NCI NIH HHS/United States
U24 CA210957/CA/NCI NIH HHS/United States
FC001202/CRUK_/Cancer Research UK/United Kingdom
A21777/CRUK_/Cancer Research UK/United Kingdom